| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.1M | — | +9.8% |
| Cost of Revenue | $15.5M | — | +7.4% |
| SG&A Expense | $7.7M | — | +17.0% |
| Operating Income | -$8.2M | — | -5.8% |
| Interest Expense | $1.1M | — | -16.9% |
| Net Income | -$9.3M | — | -2.5% |
| EPS (Basic) | -$0.07 | — | +22.2% |
| EPS (Diluted) | -$0.07 | — | +22.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.3M | +275.8% | +220.5% |
| Accounts Receivable | $1.9M | +2.2% | -31.2% |
| Inventory | $3.3M | -22.4% | -10.4% |
| Current Assets | $36.8M | +138.8% | +101.5% |
| Total Assets | $77.9M | +35.1% | +23.4% |
| Current Liabilities | $21.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.0M | — | -39.1% |
| Investing Cash Flow | -$94K | — | +77.3% |
| Financing Cash Flow | $28.3M | — | +1737.9% |
| -24.5% |
| Long-term Debt | $18.4M | -4.7% | -7.8% |
| Total Liabilities | $54.1M | -5.6% | -8.1% |
| Stockholders' Equity | $18.8M | +510.2% | +2705.7% |